Cargando…

Corrigendum to “Hypothermia Reduces Toll-Like Receptor 3-Activated Microglial Interferon-β and Nitric Oxide Production”

Detalles Bibliográficos
Autores principales:	Matsui, Tomohiro, Motoki, Yukari, Yoshida, Yusuke
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2015
Materias:	Corrigendum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4379432/ https://www.ncbi.nlm.nih.gov/pubmed/25852235 http://dx.doi.org/10.1155/2015/136296

Ejemplares similares

Hypothermia Reduces Toll-Like Receptor 3-Activated Microglial Interferon-β and Nitric Oxide Production
por: Matsui, Tomohiro, et al.
Publicado: (2013)

Corrigendum: Amyloid‐β activates NLRP3 inflammasomes by affecting microglial immunometabolism through the Syk‐AMPK pathway
Publicado: (2022)

Corrigendum: Moderate and Deep Hypothermia Produces Hyporesposiveness to Phenylephrine in Isolated Rat Aorta
por: Cho, Jun Woo, et al.
Publicado: (2014)

Corrigendum to ‘Toll-like receptors in immunity and inflammatory diseases: Past, present, and future’ [International Immunopharmacology 59 (2018) 391–412]
por: Kumar, Vijay
Publicado: (2018)

Corrigendum to “MUTYH Actively Contributes to Microglial Activation and Impaired Neurogenesis in the Pathogenesis of Alzheimer's Disease”
por: Mizuno, Yuri, et al.
Publicado: (2023)

Toll-like receptors 7 and 8 expression correlates with the expression of immune biomarkers and positively predicts the clinical outcome of patients with melanoma [Corrigendum]
Publicado: (2017)

Corrigendum to “Long-Term Nitric Oxide Exposure Enhances Lung Cancer Cell Migration”
por: Sanuphan, Arpasinee, et al.
Publicado: (2015)

Corrigendum to “Toll-Like Receptor 4–Myeloid Differentiation Primary Response Gene 88 Pathway Is Involved in the Shikonin Treatment of CIA by Regulating Treg/Th17 Expression”
por: Dai, Qiaomei, et al.
Publicado: (2019)

Corrigendum to “Clinical Outcomes of Critically Ill Patients Using Inhaled Nitric Oxide (iNO) during Intrahospital Transport”
por: Koyfman, Leonid, et al.
Publicado: (2021)

Corrigendum to “Ginsenoside Ro, an oleanolic saponin of Panax ginseng, exerts anti-inflammatory effect by direct inhibiting toll like receptor 4 signaling pathway” [J Ginseng Res 46 (2022) 156–166]
por: Xu, Hong-Lin, et al.
Publicado: (2022)

Corrigendum in “Virus C genotype predisposes to primary hypothyroidism during interferon-α treatment for chronic hepatitis C”
por: Pavan, Maria Helena Postal, et al.
Publicado: (2013)

Corrigendum to “Honokiol Eliminates Human Oral Cancer Stem-Like Cells Accompanied with Suppression of Wnt/β-Catenin Signaling and Apoptosis Induction”
por: Yao, Chih-Jung, et al.
Publicado: (2017)

Corrigendum: Targeting prion-like protein spreading in neurodegenerative diseases
Publicado: (2018)

Corrigendum: Early active immunization with Aβ(3–10)-KLH vaccine reduces tau phosphorylation in the hippocampus and protects cognition of mice
Publicado: (2020)

Therapeutic Options for Metallo-β-Lactamase-Producing Enterobacterales [Corrigendum]
Publicado: (2021)

Corrigendum: Analysis of tick-borne encephalitis virus-induced host responses in human cells of neuronal origin and interferon-mediated protection
por: Selinger, Martin, et al.
Publicado: (2018)

Corrigendum to “Low-Level Laser Irradiation Exerts Antiaggregative Effect on Human Platelets Independently on the Nitric Oxide Metabolism and Release of Platelet Activation Markers”
por: Rola, Piotr, et al.
Publicado: (2018)

Corrigendum: Extended-spectrum β-lactamase-producing and carbapenemase-producing Enterobacteriaceae
por: Wilson, Hayley, et al.
Publicado: (2018)

Corrigendum to “Plants as Useful Vectors to Reduce Environmental Toxic Arsenic Content”
por: Mirza, Nosheen, et al.
Publicado: (2018)

Corrigendum to “Phenotypic Detection of Metallo-β-Lactamase in Imipenem-Resistant Pseudomonas aeruginosa”
por: Khosravi, Yalda, et al.
Publicado: (2016)

Corrigendum to “Nitric oxide biosensor uncovers diminished ferrous iron-dependency of cultured cells adapted to physiological oxygen levels” [Redox Biol. 53 (2022) 102319]
por: Sevimli, Gulsah, et al.
Publicado: (2022)

Reduced Variability of Endurance Time in New Protocols for Exercise Tests in COPD [Corrigendum]
Publicado: (2021)

Corrigendum to “Effectiveness of interventions to reduce homelessness: A systematic review and meta‐analysis”
Publicado: (2023)

Corrigendum to “Young-Adult Male Rats' Vulnerability to Chronic Mild Stress Is Reflected by Anxious-Like instead of Depressive-Like Behaviors”
por: Herrera-Pérez, José Jaime, et al.
Publicado: (2017)

Corrigendum to “β-Catenin-Dependent Signaling Pathway Contributes to Renal Fibrosis in Hypertensive Rats”
por: Cuevas, Catherina A., et al.
Publicado: (2016)

Fabrication of novel vesicles of triptolide for antirheumatoid activity with reduced toxicity in vitro and in vivo [Corrigendum]
Publicado: (2019)

Corrigendum to “Serum Procalcitonin Levels in Acute Encephalopathy with Biphasic Seizures and Late Reduced Diffusion”
por: Fujii, Yosuke, et al.
Publicado: (2019)

Corrigendum to “Antitumor Molecular Mechanism of Chlorogenic Acid on Inducting Genes GSK-3β and APC and Inhibiting Gene β-Catenin”
por: Xu, Ruoshi, et al.
Publicado: (2015)

Corrigendum to “Optimal Hemoglobin A1c Levels for Screening of Diabetes and Prediabetes in the Japanese Population”
por: Shimodaira, Masanori, et al.
Publicado: (2017)

Construction and in vivo/in vitro Evaluation of a Nanoporous Ion-Responsive Targeted Drug Delivery System for Recombinant Human Interferon α-2b Delivery [Corrigendum]
Publicado: (2021)

Promotion of microglial phagocytosis by tuftsin stimulates remyelination inexperimental autoimmune en- cephalomyelitis
por: Bao, Zheng, et al.
Publicado: (2020)

Corrigendum
Publicado: (2008)

Corrigendum
por: Dontas, Anastasios S, et al.
Publicado: (2008)

Corrigendum
Publicado: (2006)

Corrigendum
Publicado: (2007)

Corrigendum
Publicado: (2007)

Corrigendum
Publicado: (2007)

Corrigendum
Publicado: (2006)

CORRIGENDUM
por: Sethi, Sujata, et al.
Publicado: (2001)

Corrigendum
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_ogohl8v59k0slo34r7p07navc3